CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 38 enrolled
Drug / intervention
Broccoli sprout extract (BSE)drug
Likely dose
Broccoli sprout extract (BSE) 1.25 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00882115
NCT00882115N/ACompleted

Broccoli Sprout Extract Effects on the Inflammatory Response to Diesel Exhaust Particles in the Nose

University of California, Los Angeles·interventional·Posted Apr 16, 2009·Updated Sep 20, 2019

In Brief

A clinical study evaluating Broccoli sprout extract (BSE) for Allergic Airway Disease. Completed, enrolled 38 participants across 1 site.

Detailed Summary

Allergic airway disease is a term used to describe conditions such as allergic rhinitis and asthma. Among other causative agents, air pollutants and diesel exhaust in particular, have been shown to create and also worsen existing allergic airway disease. These inhaled pollution particles have oxidative properties that drive inflammation-related effects through specific metabolic-associated processes. These processes are not adequately suppressed by current therapeutics. The purpose of this study is to explore the effects of broccoli sprout extract on the inflammatory process in the nose caused by diesel exhaust particles, which are important elements in air pollution. Broccoli sprout extract is a very potent inducer of Phase II enzymes (natural antioxidants).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 16, 2009
Enrollment StartJul 10, 2009
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 17.2 years ago

Interventions

Broccoli sprout extract (BSE)drug

BSE will be ingested by drinking a liquid formula containing 1.25 g BSE in a volume equaling 1 cup daily for 4 consecutive days in the BSE intervention phase.